Sara Vannortwick
Pediatric Orthopaedic Surgery Charleston, SC Medical Doctor
NPI 1952657827 CMS profile 4212585
171 Ashley Ave, Charleston, SC 29425
General payments
$35,394
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$5,808
Through program year 2025, Sara Vannortwick of Charleston, SC is reported in the CMS Open Payments database as having received $35,394 across 50 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $5,808 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 90th percentile of Pediatric Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $149 | 3 | |
| 2024 | General | $32,279 | 27 | |
| 2023 | General | $137 | 2 | |
| 2021 | General | $293 | 4 | |
| 2020 | General | $17 | 1 | |
| 2019 | General | $2,518 | 13 |
Beside peers
- Sara Vannortwick
- Pediatric Orthopaedic Surgery median
- Middle half of Pediatric Orthopaedic Surgery
- National median
In program year 2025, general payments to Sara Vannortwick were reported at $149. Among 495 Pediatric Orthopaedic Surgery profiles paid that year, the median was $271 and the middle half received between $89 and $1,158.
Show as a table
| Year | Sara Vannortwick | Pediatric Orthopaedic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,518 | $355 | $117–$1,889 | $163 |
| 2020 | $17 | $290 | $62–$1,625 | $114 |
| 2021 | $293 | $628 | $75–$2,400 | $132 |
| 2022 | $0 | $427 | $115–$2,170 | $149 |
| 2023 | $137 | $265 | $98–$1,497 | $160 |
| 2024 | $32,279 | $255 | $84–$1,694 | $164 |
| 2025 | $149 | $271 | $89–$1,158 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
50 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Orthopaedic Surgery in South Carolina
Robert Murphy
Pediatric Orthopaedic Surgery · Charleston, SC
Thomas Gibson
Pediatric Orthopaedic Surgery · Greenville, SC
David Lazarus
Pediatric Orthopaedic Surgery · Greenville, SC
Mark Locke
Pediatric Orthopaedic Surgery · Columbia, SC
Michael Horan
Pediatric Orthopaedic Surgery · Columbia, SC
Norman Ward
Pediatric Orthopaedic Surgery · Charleston, SC
Related records
Pediatric Orthopaedic Surgery in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Orthopaedic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.